Sec Form 4 Filing - Roberts Jonathan C @ CVS HEALTH Corp - 2022-04-01

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Roberts Jonathan C 2. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [ CVS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) EVP & Chief Operating Officer (Last) (First) (Middle) ONE CVS DRIVE 3. Date of Earliest Transaction (MM/DD/YY) 04/01/2022 (Street) WOONSOCKET, RI02895- 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 426,024.717 D Common Stock 38,192 I By GRAT Common Stock (restricted) 12,812 D ESOP Common Stock 6,155.5059 I By ESOP Stock Unit 341,392.3767 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option $ 101.09 04/01/2022 A 25,987 04/01/2023( 1 ) 04/01/2032 Common Stock 25,987 $ 101.09 25,987 D Phantom Stock Credits $ 1 ( 2 ) ( 2 ) Common Stock 1,416.3128 1,416.3128 D Stock Option $ 104.82 04/01/2017( 3 ) 04/01/2023 Common Stock 161,318 161,318 D Stock Option $ 78.05 04/03/2018( 4 ) 04/03/2024 Common Stock 200,358 200,358 D Stock Option $ 62.21 04/01/2019( 5 ) 04/01/2025 Common Stock 248,131 248,131 D Stock Option $ 54.19 04/01/2020( 6 ) 04/01/2029 Common Stock 303,010 303,010 D Stock Option $ 58.34( 7 ) 04/01/2021( 8 ) 04/01/2030 Common Stock 239,355 239,355 D Stock Option $ 74.3 04/01/2022( 9 ) 04/01/2031 Common Stock 172,772 172,772 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Roberts Jonathan C ONE CVS DRIVE WOONSOCKET, RI02895- EVP & Chief Operating Officer Signatures Jonathan C. Roberts 04/05/2022 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Option becomes exercisable in four equal installments, commencing 4/1/2023. ( 2 )Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. ( 3 )Option became exercisable in four equal annual installments, commencing 4/1/2017. ( 4 )Option became exercisable in four equal annual installments, commencing 4/3/2018. ( 5 )Option became exercisable in four equal annual installments, commencing 4/1/2019. ( 6 )Option became exercisable in four equal annual installments, commencing 4/1/2020. ( 7 )The number of shares subject to the option were calculated using a 30-day average price. ( 8 )Options became exercisable in four equal installments, commencing 4/1/2021. ( 9 )Option becomes exercisable in four equal installments, commencing 4/1/2022.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Vi olations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.